ClinicalTrials.Veeva

Menu

Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status

Enrolling

Conditions

Caregiver Burden

Treatments

Other: I-HoME

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06488157
23-01025643
K76AG059997-04S1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years old and < 100 years
  • English speaking
  • Providing care to an ADRD patient who is age ≥ 65 years old and < 105 years who is a stage 7a-f on the Functional Assessment Staging Tool (FAST) scale

Exclusion criteria

  • Non-English speaking
  • <18 years old or >100 years old

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Intervention (I-HoME)
Experimental group
Description:
Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs.
Treatment:
Other: I-HoME

Trial contacts and locations

1

Loading...

Central trial contact

Veerawat Phongtankuel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems